Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?

As of April 8, 2026, expert sentiment toward Allogene Therapeutics, Inc. (NASDAQ:ALLO) remains bullish, with 85% of analysts issuing “Buy” ratings connected the stock. The statement terms people of $7.50 implies an upside of 186.26%.

On March 13, 2026, Piper Sandler accrued its terms people from $7 to $8 and kept an “Overweight” standing connected Allogene Therapeutics, Inc. (NASDAQ:ALLO). The steadfast stated that capitalist attraction was shifting to the April interim investigation from the ALPHA3 survey successful first-line consolidation LBCL, portion noting a favorable setup for cema-cel to execute a 25%–30% MRD clearance vantage implicit observation.

This improvement followed Allogene Therapeutics, Inc. (NASDAQ:ALLO)’s March 12, 2026, Q4 and full-year 2025 results, successful which absorption referred to ALPHA3 arsenic a important turning point, portion besides noting that the survey whitethorn find whether allogeneic CAR-T tin beryllium administered astatine a biologic-like standard and turn beyond world centers.

Allogene Therapeutics, Inc. (NASDAQ:ALLO) has $258.3 cardinal successful cash, currency equivalents, and investments astatine the extremity of 2025, extending the company’s runway into Q1 2028, portion guiding to $150 cardinal successful operating currency expenses successful 2026. Net nonaccomplishment for the 4th fourth was $38.8 cardinal ($0.17 per share) versus a full-year nett nonaccomplishment of $190.9 million, oregon $0.87 per share.

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is simply a clinical-stage biotechnology institution dedicated to the improvement of off-the-shelf allogeneic CAR-T compartment therapies for crab and autoimmune diseases. The company’s extremity is to supply a scalable, readily disposable compartment therapy derived from steadfast donors.

While we admit the imaginable of ALLO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.